Chimerism and bone marrow based therapies in transplantation

Area of Science:

• Regenerative Medicine
• Immunology
• Transplantation Science

Background:

• Composite tissue allotransplantation offers life-enhancing reconstructions but faces challenges due to the high antigenic load of multiple tissue types.
• Current immunosuppressive drugs prevent allograft rejection but have significant side effects, limiting widespread clinical application.
• Achieving permanent immunotolerance is crucial for the long-term success of allotransplantation.

Purpose of the Study:

• To review bone marrow-based therapy protocols for inducing tolerance in transplantation.
• To explore the immunomodulatory potential of bone marrow in facilitating allograft acceptance.
• To categorize bone marrow-based therapies for solid organ and composite tissue transplantation.

Main Methods:

• Literature review of clinical and experimental studies on bone marrow therapy in transplantation.
• Analysis of tolerance induction protocols utilizing bone marrow.
• Categorization of reviewed protocols based on transplant type (solid organ vs. composite tissue).

Main Results:

• Bone marrow therapy is a key component in protocols aimed at achieving permanent immunotolerance.
• Bone marrow demonstrates immunomodulatory properties that can facilitate allograft acceptance.
• Therapeutic strategies are presented for both solid organ and composite tissue allotransplantation.

Conclusions:

• Bone marrow-based therapies represent a promising strategy to overcome the limitations of current immunosuppression in allotransplantation.
• Further research into bone marrow therapy can advance the field of transplantation towards achieving long-term graft acceptance and reducing adverse effects.
• This review consolidates existing knowledge, guiding future therapeutic development for composite tissue allotransplantation.